[EWTX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[EWTX] Edgewise Therapeutics, Inc.
Announcement Date
22-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -17.23%
YoY- -79.95%
Quarter Report
EWTX's Result
EWTX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 2,252 0 0 0 -
PBT -30,143 -19,415 -12,696 -6,342 68.13%
Tax 3,604 -2,664 42,813 0 -
NP -30,143 -16,751 -12,696 -6,342 68.13%
Tax Rate - - - - -
Total Cost 32,395 16,751 12,696 6,342 72.22%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -1,338.50 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.47 -0.26 -0.26 -0.31 14.88%
EPS Diluted -0.47 -0.26 -0.26 -0.31 14.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.